GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (STU:56S1) » Definitions » Total Long-Term Liabilities

Sartorius Stedim Biotech (STU:56S1) Total Long-Term Liabilities : €3,331 Mil (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Sartorius Stedim Biotech Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Sartorius Stedim Biotech's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was €3,331 Mil.

Sartorius Stedim Biotech Total Long-Term Liabilities Historical Data

The historical data trend for Sartorius Stedim Biotech's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Total Long-Term Liabilities Chart

Sartorius Stedim Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 827.89 1,180.70 1,515.30 4,119.00 3,293.80

Sartorius Stedim Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,597.00 3,270.80 3,300.80 3,293.80 3,330.80

Sartorius Stedim Biotech Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Sartorius Stedim Biotech Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (STU:56S1) » Definitions » Total Long-Term Liabilities
Comparable Companies
XPAR:AMPLI XPAR:ALCJ XPAR:MLBON XPAR:ALSPW XPAR:ALSAF ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XSWX:STMN COO BAX WST NZSE:FPH ALGN SOLV
Traded in Other Exchanges
SRTOY:USA SDMHF:USA DIMp:UK 0RG8:UK DIM:France 56S1:Germany DIM:Austria
Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Website
https://www.sartorius.com
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.

Sartorius Stedim Biotech Headlines

No Headlines